1. HBW Insight
  2. >>Ingredients & Safety

J&J Starts First Baby Powder Recall Linked To Asbestos Finding

 
• By Malcolm Spicer

Recall announcement doesn't mention litigation J&JU faces in multiple states alleging use of Johnson's Baby Powder causes cancer due from talc in formulation. But firm's sensitivity to consumer complaints or adverse event reports linked to brand is clear with talc-related litigation as backdrop.

Product Recall - Image

A long-simmering potential problem with talc has prompted Johnson & Johnson's first recall of a baby powder product due to the presence of sub-trace levels of chrysotile asbestos contamination.

Separately, recent updates to the Food and Drug Administration's recalls database include a second recall of cosmetics in 2019 by...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By David Ridley

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.

Gardenia Blue, OrangeOvation, StellarYellow Latest Natural Pivots In US Food Color Market

 
• By Malcolm Spicer

FDA’s fourth approval in past two months for color derived from natural sources to use in foods is Gardenia Blue Interest Group’s color additive petition for gardenia blue. Lycored launches StellarYellow and C Clear as alternatives for synthetic dyes yellow Nos. 5 and 6 and OrangeOvation C Clear for

House OMUFA Reauthorization Bill Takes On Clarifying Standards For Tests To Meet GRASE

 
• By Malcolm Spicer

Health Subcommittee will discuss reauthorizing OMUFA during a hearing on how to “maintain and improve” the public health workforce and rural health as well as access to OTC medicines.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By David Ridley

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

More from HBW Insight

US Consumer Health Q2 Earnings Preview: Baggage Comes With Costs, Expectations

 
• By Malcolm Spicer

In addition to impact from tariffs and executive suite changes, recent baggage for firms in the space include Perrigo divesting its branded Dermacosmetics business and Church & Dwight acquiring Touchland hand sanitizer brand.

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By Tom Gallen

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

Self-Testing Kits Need To Be Regulated Like OTCs, UK Researchers Argue

 
• By David Ridley

Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.